Rheumatoid Arthritis (RA) associated interstitial lung disease (ILD)

European Journal of Internal Medicine

Volumn 24, Issue 7, 2013, Pages 597-603

  O'Dwyer, David N ^a,b   Armstrong, Michelle E ^a   Cooke, Gordon ^a   Dodd, Jonathan D ^b   Veale, Douglas J ^b   Donnelly, Seamas C ^a,b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Arthritis; Interstitial lung disease; Pulmonary fibrosis; Rheumatoid

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CIGARETTE SMOKE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETANERCEPT; GAMMA INTERFERON; HEAT SHOCK PROTEIN 90; METHOTREXATE; MYCOPHENOLIC ACID; RITUXIMAB; TRANSFORMING GROWTH FACTOR BETA;

ASYMPTOMATIC DISEASE; BRONCHIECTASIS; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CORTICOSTEROID THERAPY; DIGITAL CLUBBING; DISEASE ASSOCIATION; DISEASE COURSE; DYSPNEA; EARLY DIAGNOSIS; EMPHYSEMA; HISTOPATHOLOGY; HUMAN; INCIDENCE; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG ARTERY PRESSURE; MEDICAL HISTORY; MORTALITY; PHYSICIAN; PREVALENCE; PROGNOSIS; PULMONARY HYPERTENSION; QUALITY OF LIFE; REVIEW; RHEUMATOID ARTHRITIS; THORAX RADIOGRAPHY;

ARTHRITIS; INTERSTITIAL LUNG DISEASE; PULMONARY FIBROSIS; RHEUMATOID;

ARTHRITIS, RHEUMATOID; HUMANS; LUNG DISEASES, INTERSTITIAL; PULMONARY FIBROSIS; RISK FACTORS;

EID: 84884285437     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2013.07.004     Document Type: Review

References (97)

1. K.K. Brown Rheumatoid lung disease Proc Am Thorac Soc 4 2007 443 448
2. J. Lundkvist, F. Kastang, and G. Kobelt The burden of rheumatoid arthritis and access to treatment: health burden and costs Eur J Health Econ 8 2008 S49 S60
3. T.D. Spector Rheumatoid arthritis Rheum Dis Clin North Am 16 1990 513 537
4. N.J. Minaur, R.K. Jacoby, J.A. Cosh, G. Taylor, and J.J. Rasker Outcome after 40 years with rheumatoid arthritis: a prospective study of function, disease activity, and mortality J Rheumatol Suppl 69 2004 3 8
5. S.E. Gabriel, C.S. Crowson, H.M. Kremers, M.F. Doran, C. Turesson, and W.M. O'Fallon Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years Arthritis Rheum 48 2003 54 58
6. H. Maradit-Kremers, P.J. Nicola, C.S. Crowson, K.V. Ballman, and S.E. Gabriel Cardiovascular death in rheumatoid arthritis: a population-based study Arthritis Rheum 52 2005 722 732
7. H. Hayakawa, A. Sato, S. Imokawa, M. Toyoshima, K. Chida, and M. Iwata Bronchiolar disease in rheumatoid arthritis Am J Respir Crit Care Med 154 1996 1531 1536
8. S. Homma, M. Kawabata, K. Kishi, E. Tsuboi, K. Narui, and T. Nakatani Diffuse panbronchiolitis in rheumatoid arthritis Eur Respir J 12 1998 444 452
9. G.W. Hunninghake, and A.S. Fauci Pulmonary involvement in the collagen vascular diseases Am Rev Respir Dis 119 1979 471 503
10. J. Schreiber, D. Koschel, J. Kekow, N. Waldburg, A. Goette, and R. Merget Rheumatoid pneumoconiosis (Caplan's syndrome) Eur J Intern Med 21 2010 168 172
11. N.A. Shadick, C.H. Fanta, M.E. Weinblatt, W. O'Donnell, and J.S. Coblyn Bronchiectasis. A late feature of severe rheumatoid arthritis Medicine (Baltimore) 73 1994 161 170
12. D. Antin-Ozerkis, J. Evans, A. Rubinowitz, R.J. Homer, and R.A. Matthay Pulmonary manifestations of rheumatoid arthritis Clin Chest Med 31 2010 451 478
13. G. Koduri, S. Norton, A. Young, N. Cox, P. Davies, and J. Devlin Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort Rheumatology (Oxford) 49 2010 1483 1489
14. S. Mahendran, and T. Sethi Treatments in idiopathic pulmonary fibrosis: time for a more targeted approach? QJM 105 2012 929 934
15. D. Bouros, A.U. Wells, A.G. Nicholson, T.V. Colby, V. Polychronopoulos, and P. Pantelidis Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome Am J Respir Crit Care Med 165 2002 1581 1586
16. E.J. Kim, H.R. Collard, and T.E. King Jr. Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern Chest 136 2009 1397 1405
17. E.J. Kim, B.M. Elicker, F. Maldonado, W.R. Webb, J.H. Ryu, and J.H. Van Uden Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease Eur Respir J 35 2010 1322 1328
18. B.R. Gochuico, N.A. Avila, C.K. Chow, L.J. Novero, H.P. Wu, and P. Ren Progressive preclinical interstitial lung disease in rheumatoid arthritis Arch Intern Med 168 2008 159 166
19. E. Gabbay, R. Tarala, R. Will, G. Carroll, B. Adler, and D. Cameron Interstitial lung disease in recent onset rheumatoid arthritis Am J Respir Crit Care Med 156 1997 528 535
20. S. Mori, Y. Koga, and M. Sugimoto Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis Respir Med 106 2012 1591 1599
21. S.C. Donnelly Review series - inflammation & fibrosis introduction QJM 105 2012 503
22. M.J. Hamblin, and M.R. Horton Rheumatoid arthritis-associated interstitial lung disease: diagnostic dilemma Pulm Med 2011 2011 872120
23. W.G. Dixon, K.L. Hyrich, K.D. Watson, M. Lunt, B.C.C. Consortium, and D.P. Symmons Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register Ann Rheum Dis 69 2010 1086 1091
24. B.H. Stack, and I.W. Grant Rheumatoid interstitial lung disease Br J Dis Chest 59 1965 202 211
25. W.C. Walker, and V. Wright Diffuse interstitial pulmonary fibrosis and rheumatoid arthritis Ann Rheum Dis 28 1969 252 259
26. A. Suzuki, Y. Ohosone, M. Obana, S. Mita, Y. Matsuoka, and S. Irimajiri Cause of death in 81 autopsied patients with rheumatoid arthritis J Rheumatol 21 1994 33 36
27. S.T. Frank, J.G. Weg, L.E. Harkleroad, and R.F. Fitch Pulmonary dysfunction in rheumatoid disease Chest 63 1973 27 34
28. T. Bongartz, C. Nannini, Y.F. Medina-Velasquez, S.J. Achenbach, C.S. Crowson, and J.H. Ryu Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study Arthritis Rheum 62 2010 1583 1591
29. A.L. Olson, J.J. Swigris, D.B. Sprunger, A. Fischer, E.R. Fernandez-Perez, and J. Solomon Rheumatoid arthritis-interstitial lung disease-associated mortality Am J Respir Crit Care Med 183 2011 372 378
30. D.E. O'Donnell, J. Ora, K.A. Webb, P. Laveneziana, and D. Jensen Mechanisms of activity-related dyspnea in pulmonary diseases Respir Physiol Neurobiol 167 2009 116 132
31. A. Shahane Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis Rheumatol Int 33 7 2013 1655 1667
32. N. Udayakumar, S. Venkatesan, and C. Rajendiran Pulmonary hypertension in rheumatoid arthritis - relation with the duration of the disease Int J Cardiol 127 2008 410 412
33. H.K. Lee, D.S. Kim, B. Yoo, J.B. Seo, J.Y. Rho, and T.V. Colby Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease Chest 127 2005 2019 2027
34. S.A. Yousem, T.V. Colby, and C.B. Carrington Lung biopsy in rheumatoid arthritis Am Rev Respir Dis 131 1985 770 777
35. Y. Nakamura, T. Suda, Y. Kaida, M. Kono, H. Hozumi, and D. Hashimoto Rheumatoid lung disease: prognostic analysis of 54 biopsy-proven cases Respir Med 106 2012 1164 1169
36. M. Demedts, and U. Costabel ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias Eur Respir J 19 2002 794 796
37. K.R. Flaherty, E.L. Thwaite, E.A. Kazerooni, B.H. Gross, G.B. Toews, and T.V. Colby Radiological versus histological diagnosis in UIP and NSIP: survival implications Thorax 58 2003 143 148
38. G.W. Hunninghake, M.B. Zimmerman, D.A. Schwartz, T.E. King Jr., J. Lynch, and R. Hegele Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 164 2001 193 196
39. T. Yoshinouchi, Y. Ohtsuki, J. Fujita, I. Yamadori, S. Bandoh, and T. Ishida Nonspecific interstitial pneumonia pattern as pulmonary involvement of rheumatoid arthritis Rheumatol Int 26 2005 121 125
40. W.D. Travis, G. Hunninghake, T.E. King Jr., D.A. Lynch, T.V. Colby, and J.R. Galvin Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project Am J Respir Crit Care Med 177 2008 1338 1347
41. American Thoracic Society Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS) Am J Respir Crit Care Med 161 2000 646 664
42. J.W. Song, K.H. Do, M.Y. Kim, S.J. Jang, T.V. Colby, and D.S. Kim Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia Chest 136 2009 23 30
43. C. Turesson, E.L. Matteson, T.V. Colby, Z. Vuk-Pavlovic, R. Vassallo, and C.M. Weyand Increased CD4 + T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis Arthritis Rheum 52 2005 73 79
44. G. Raghu, H.R. Collard, J.J. Egan, F.J. Martinez, J. Behr, and K.K. Brown An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med 183 2011 788 824
45. K.G. Saag, S. Kolluri, R.K. Koehnke, T.A. Georgou, J.W. Rachow, and G.W. Hunninghake Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities Arthritis Rheum 39 1996 1711 1719
46. R. Luukkainen, M. Saltyshev, R. Pakkasela, E. Nordqvist, H. Huhtala, and M. Hakala Relationship of rheumatoid factor to lung diffusion capacity in smoking and non-smoking patients with rheumatoid arthritis Scand J Rheumatol 24 1995 119 120
47. F.F. Ayhan-Ardic, O. Oken, Z.R. Yorgancioglu, N. Ustun, and F.D. Gokharman Pulmonary involvement in lifelong non-smoking patients with rheumatoid arthritis and ankylosing spondylitis without respiratory symptoms Clin Rheumatol 25 2006 213 218
48. K.G. Saag, J.R. Cerhan, S. Kolluri, K. Ohashi, G.W. Hunninghake, and D.A. Schwartz Cigarette smoking and rheumatoid arthritis severity Ann Rheum Dis 56 1997 463 469
49. C. Turesson, L.T. Jacobsson, G. Sturfelt, E.L. Matteson, L. Mathsson, and J. Ronnelid Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis Ann Rheum Dis 66 2007 59 64
50. J. Ronnelid, M.C. Wick, J. Lampa, S. Lindblad, B. Nordmark, and L. Klareskog Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression Ann Rheum Dis 64 2005 1744 1749
51. L. Klareskog, P. Stolt, K. Lundberg, H. Kallberg, C. Bengtsson, and J. Grunewald A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination Arthritis Rheum 54 2006 38 46
52. T. Bongartz, T. Cantaert, S.R. Atkins, P. Harle, J.L. Myers, and C. Turesson Citrullination in extra-articular manifestations of rheumatoid arthritis Rheumatology (Oxford) 46 2007 70 75
53. D. Makrygiannakis, M. Hermansson, A.K. Ulfgren, A.P. Nicholas, A.J. Zendman, and A. Eklund Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells Ann Rheum Dis 67 2008 1488 1492
54. I. Alexiou, A. Germenis, A. Koutroumpas, A. Kontogianni, K. Theodoridou, and L.I. Sakkas Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis Clin Rheumatol 27 2008 511 513
55. L. Harlow, I.O. Rosas, B.R. Gochuico, T.R. Mikuls, P.F. Dellaripa, and C.V. Oddis Identification of citrullinated heat shock protein 90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease Arthritis Rheum 65 2013 869 879
56. A. Fischer, J.J. Solomon, R.M. du Bois, K.D. Deane, A.L. Olson, and E.R. Fernandez-Perez Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease Respir Med 106 2012 1040 1047
57. F. Aubart, B. Crestani, P. Nicaise-Roland, F. Tubach, C. Bollet, and K. Dawidowicz High levels of anti-cyclic citrullinated peptide autoantibodies are associated with co-occurrence of pulmonary diseases with rheumatoid arthritis J Rheumatol 38 2011 979 982
58. A.M. Gizinski, M. Mascolo, J.L. Loucks, A. Kervitsky, R.T. Meehan, and K.K. Brown Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA Clin Rheumatol 28 2009 611 613
59. J.P. Michalski, C.C. McCombs, E. Scopelitis, J.J. Biundo Jr., and T.A. Medsger Jr. Alpha 1-antitrypsin phenotypes, including M subtypes, in pulmonary disease associated with rheumatoid arthritis and systemic sclerosis Arthritis Rheum 29 1986 586 591
60. P.J. Charles, M.C. Sweatman, J.R. Markwick, and R.N. Maini HLA-B40: a marker for susceptibility to lung disease in rheumatoid arthritis Dis Markers 9 1991 97 101
61. Y. Sugiyama, S. Ohno, S. Kano, H. Maeda, and S. Kitamura Diffuse panbronchiolitis and rheumatoid arthritis: a possible correlation with HLA-B54 Intern Med 33 1994 612 614
62. D.A. Gordon, J.L. Stein, and I. Broder The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases Am J Med 54 1973 445 452
63. A.L. Olson, J.J. Swigris, and K.K. Brown Clinical trials and tribulations - lessons from pulmonary fibrosis QJM 105 2012 1043 1047
64. K.R. Flaherty, T.V. Colby, W.D. Travis, G.B. Toews, J. Mumford, and S. Murray Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease Am J Respir Crit Care Med 167 2003 1410 1415
65. C. Agusti, A. Xaubet, J. Roca, A.G. Agusti, and R. Rodriguez-Roisin Interstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a two year follow up Thorax 47 1992 1035 1040
66. A.U. Wells, P. Cullinan, D.M. Hansell, M.B. Rubens, C.M. Black, and A.J. Newman-Taylor Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis Am J Respir Crit Care Med 149 1994 1583 1590
67. W.W. Douglas, H.D. Tazelaar, T.E. Hartman, R.P. Hartman, P.A. Decker, and D.R. Schroeder Polymyositis-dermatomyositis-associated interstitial lung disease Am J Respir Crit Care Med 164 2001 1182 1185
68. J.K. Dawson, H.E. Fewins, J. Desmond, M.P. Lynch, and D.R. Graham Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis Ann Rheum Dis 61 2002 517 521
69. N.A. Naji, M.C. Connor, S.C. Donnelly, and T.J. McDonnell Effectiveness of pulmonary rehabilitation in restrictive lung disease J Cardiopulm Rehabil 26 2006 237 243
70. A.E. Holland, C.J. Hill, M. Conron, P. Munro, and C.F. McDonald Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease Thorax 63 2008 549 554
71. V. Cottin, H. Nunes, L. Mouthon, D. Gamondes, R. Lazor, and E. Hachulla Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease Arthritis Rheum 63 2011 295 304
72. C.D. Patterson, W.E. Harville, and J.A. Pierce Rheumatoid lung disease Ann Intern Med 62 1965 685 697
73. A. Azuma, T. Nukiwa, E. Tsuboi, M. Suga, S. Abe, and K. Nakata Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 171 2005 1040 1047
74. L. Richeldi, U. Costabel, M. Selman, D.S. Kim, D.M. Hansell, and A.G. Nicholson Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis N Engl J Med 365 2011 1079 1087
75. H.K. Chang, W. Park, and D.S. Ryu Successful treatment of progressive rheumatoid interstitial lung disease with cyclosporine: a case report J Korean Med Sci 17 2002 270 273
76. A. Schnabel, M. Reuter, and W.L. Gross Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases Arthritis Rheum 41 1998 1215 1220
77. C. Kelly, and V. Saravanan Treatment strategies for a rheumatoid arthritis patient with interstitial lung disease Expert Opin Pharmacother 9 2008 3221 3230
78. D.A. Zisman, W.J. McCune, G. Tino, and J.P. Lynch III Drug-induced pneumonitis: the role of methotrexate Sarcoidosis Vasc Diffuse Lung Dis 18 2001 243 252
79. Y. Kamata, H. Nara, T. Kamimura, K. Haneda, M. Iwamoto, and J. Masuyama Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction Intern Med 43 2004 1201 1204
80. A.L. Gaffo, and G.S. Alarcon Methotrexate is not associated with progression of interstitial lung disease in rheumatoid arthritis Arch Intern Med 168 2008 1927 1928
81. K. Hagiwara, T. Sato, S. Takagi-Kobayashi, S. Hasegawa, N. Shigihara, and O. Akiyama Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis J Rheumatol 34 2007 1151 1154
82. A.J. Ostor, A.J. Crisp, M.F. Somerville, and D.G. Scott Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab BMJ 329 2004 1266
83. A. Schoe, N.E. van der Laan-Baalbergen, T.W. Huizinga, F.C. Breedveld, and J.M. van Laar Pulmonary fibrosis in a patient with rheumatoid arthritis treated with adalimumab Arthritis Rheum 55 2006 157 159
84. R. Perez-Alvarez, M. Perez-de-Lis, C. Diaz-Lagares, J.M. Pego-Reigosa, S. Retamozo, and A. Bove Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases Semin Arthritis Rheum 41 2011 256 264
85. R. Vassallo, E. Matteson, and C.F. Thomas Jr. Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition Chest 122 2002 1093 1096
86. K.M. Antoniou, M. Mamoulaki, K. Malagari, H.D. Kritikos, D. Bouros, and N.M. Siafakas Infliximab therapy in pulmonary fibrosis associated with collagen vascular disease Clin Exp Rheumatol 25 2007 23 28
87. S.T. Panopoulos, and P.P. Sfikakis Biological treatments and connective tissue disease associated interstitial lung disease Curr Opin Pulm Med 17 2011 362 367
88. S. O'Beirne, I.P. Counihan, and M.P. Keane Interstitial lung disease and lung transplantation Semin Respir Crit Care Med 31 2010 139 146
89. D. Shitrit, A. Amital, N. Peled, Y. Raviv, B. Medalion, and M. Saute Lung transplantation in patients with scleroderma: case series, review of the literature, and criteria for transplantation Clin Transplant 23 2009 178 183
90. L.A. Saketkoo, and L.R. Espinoza Rheumatoid arthritis interstitial lung disease: mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug Arch Intern Med 168 2008 1718 1719
91. A. Fischer, K.K. Brown, R.M. Du Bois, S.K. Frankel, G.P. Cosgrove, and E.R. Fernandez-Perez Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease J Rheumatol 40 2013 640 646
92. J.J. Swigris, A.L. Olson, A. Fischer, D.A. Lynch, G.P. Cosgrove, and S.K. Frankel Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease Chest 130 2006 30 36
93. P.P. Tak, W. Rigby, A. Rubbert-Roth, C. Peterfy, R.F. van Vollenhoven, and W. Stohl Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE Ann Rheum Dis 71 2012 351 357
94. R.F. van Vollenhoven, P. Emery, C.O. Bingham III, E.C. Keystone, R.M. Fleischmann, and D.E. Furst Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients Ann Rheum Dis 2012 [Epub ahead of print]
95. D. Daoussis, S.N. Liossis, A.C. Tsamandas, C. Kalogeropoulou, F. Paliogianni, and C. Sirinian Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosis Clin Exp Rheumatol 30 2012 S17 S22
96. Y. Braun-Moscovici, Y. Butbul-Aviel, L. Guralnik, K. Toledano, D. Markovits, and A. Rozin Rituximab: rescue therapy in life-threatening complications or refractory autoimmune diseases: a single center experience Rheumatol Int 33 2013 1495 1504
97. A.V. Hadjinicolaou, M.K. Nisar, H. Parfrey, E.R. Chilvers, and A.J. Ostor Non-infectious pulmonary toxicity of rituximab: a systematic review Rheumatology (Oxford) 51 2012 653 662